Multiple activities of ligb potentiate virulence of Leptospira interrogans: Inhibition of alternative and classical pathways of complement

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Choy, Henry A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HACme Lab Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; FIBRINOGEN; FIBRONECTIN; IMMUNOGLOBULIN; PROTEIN LIGB; RECOMBINANT LIGB7' 12; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT INHIBITION; CONTROLLED STUDY; ERYTHROCYTE; HEMOLYSIS; HOMEOSTASIS; HOST PARASITE INTERACTION; HUMAN; INNATE IMMUNITY; LEPTOSPIRA; LEPTOSPIRA BIFLEXA; LEPTOSPIRA INTERROGANS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SAPROTROPH;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; COMPLEMENT C3B; COMPLEMENT C4B; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; HUMANS; IMMUNE SERA; LEPTOSPIRA INTERROGANS; MICROBIAL VIABILITY; PROTEIN BINDING; RABBITS; SHEEP; VIRULENCE;

LEPTOSPIRA; LEPTOSPIRA BIFLEXA; LEPTOSPIRA INTERROGANS;

EID: 84864185721     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041566     Document Type: Article

References (62)

1. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, et al. (2003) Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3: 757-771.
2. Haake DA, Dundoo M, Cader R, Kubak BM, Hartskeerl RA, et al. (2002) Leptospirosis, water sports, and chemoprophylaxis. Clin Infect Dis 34: e40-43.
3. Ko AI, Galvao Reis M, Ribeiro Dourado CM, Johnson WD Jr, Riley LW, (1999) Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet 354: 820-825.
4. Levett PN, (2001) Leptospirosis. Clin Microbiol Rev 14: 296-326.
5. McBride AJ, Athanazio DA, Reis MG, Ko AI, (2005) Leptospirosis. Curr Opin Infect Dis 18: 376-386.
6. Monahan AM, Miller IS, Nally JE, (2009) Leptospirosis: risks during recreational activities. J Appl Microbiol 107: 707-716.
7. Narita M, Fujitani S, Haake DA, Paterson DL, (2005) Leptospirosis after recreational exposure to water in the Yaeyama islands, Japan. Am J Trop Med Hyg 73: 652-656.
8. Palaniappan RU, Ramanujam S, Chang YF, (2007) Leptospirosis: pathogenesis, immunity, and diagnosis. Curr Opin Infect Dis 20: 284-292.
9. Matsunaga J, Sanchez Y, Xu X, Haake DA, (2005) Osmolarity, a key environmental signal controlling expression of leptospiral proteins LigA and LigB and the extracellular release of LigA. Infect Immun 73: 70-78.
10. Matsunaga J, Lo M, Bulach DM, Zuerner RL, Adler B, et al. (2007) Response of Leptospira interrogans to physiologic osmolarity: relevance in signaling the environment-to-host transition. Infect Immun 75: 2864-2874.
11. Choy HA, Kelley MM, Chen TL, Moller AK, Matsunaga J, et al. (2007) Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect Immun 75: 2441-2450.
12. Figueira CP, Croda J, Choy HA, Haake DA, Reis MG, et al. (2011) Heterologous expression of pathogen-specific genes ligA and ligB in the saprophyte Leptospira biflexa confers enhanced adhesion to cultured cells and fibronectin. BMC Microbiol 11: 129.
13. Lin YP, Chang YF, (2007) A domain of the Leptospira LigB contributes to high affinity binding of fibronectin. Biochem Biophys Res Commun 362: 443-448.
14. Lin YP, McDonough SP, Sharma Y, Chang YF, (2010) The terminal immunoglobulin-like repeats of LigA and LigB of Leptospira enhance their binding to gelatin binding domain of fibronectin and host cells. PLoS One 5: e11301.
15. Choy HA, Kelley MM, Croda J, Matsunaga J, Babbitt JT, et al. (2011) The multifunctional LigB adhesin binds homeostatic proteins with potential roles in cutaneous infection by pathogenic Leptospira interrogans. PLoS One 6: e16879.
16. Lin YP, McDonough SP, Sharma Y, Chang YF, (2011) Leptospira immunoglobulin-like protein B (LigB) binding to the C-terminal fibrinogen alphaC domain inhibits fibrin clot formation, platelet adhesion and aggregation. Mol Microbiol 79: 1063-1076.
17. Cinco M, (2010) New insights into the pathogenicity of leptospires: evasion of host defences. New Microbiol 33: 283-292.
18. Foster TJ, (2009) Colonization and infection of the human host by staphylococci: adhesion, survival and immune evasion. Vet Dermatol 20: 456-470.
19. Fraga TR, Barbosa AS, Isaac L, (2011) Leptospirosis: aspects of innate immunity, immunopathogenesis and immune evasion from the complement system. Scand J Immunol 73: 408-419.
20. Kraiczy P, Wurzner R, (2006) Complement escape of human pathogenic bacteria by acquisition of complement regulators. Mol Immunol 43: 31-44.
21. Lambris JD, Ricklin D, Geisbrecht BV, (2008) Complement evasion by human pathogens. Nat Rev Microbiol 6: 132-142.
22. Luo S, Blom AM, Rupp S, Hipler UC, Hube B, et al. (2011) The pH-regulated antigen 1 of Candida albicans binds the human complement inhibitor C4b-binding protein and mediates fungal complement evasion. J Biol Chem 286: 8021-8029.
23. Chung MC, Tonry JH, Narayanan A, Manes NP, Mackie RS, et al. (2011) Bacillus anthracis interacts with plasmin(ogen) to evade C3b-dependent innate immunity. PLoS One 6: e18119.
24. Bykowski T, Woodman ME, Cooley AE, Brissette CA, Brade V, et al. (2007) Coordinated expression of Borrelia burgdorferi complement regulator-acquiring surface proteins during the Lyme disease spirochete's mammal-tick infection cycle. Infect Immun 75: 4227-4236.
25. Johnson RC, Muschel LH, (1966) Antileptospiral activity of serum. I. Normal and immune serum. J Bacteriol 91: 1403-1409.
26. Johnson RC, Harris VG, (1967) Antileptospiral activity of serum. II. Leptospiral virulence factor. J Bacteriol 93: 513-519.
27. Meri T, Murgia R, Stefanel P, Meri S, Cinco M, (2005) Regulation of complement activation at the C3-level by serum resistant leptospires. Microb Pathog 39: 139-147.
28. Verma A, Hellwage J, Artiushin S, Zipfel PF, Kraiczy P, et al. (2006) LfhA, a novel factor H-binding protein of Leptospira interrogans. Infect Immun 74: 2659-2666.
29. Barbosa AS, Abreu PA, Neves FO, Atzingen MV, Watanabe MM, et al. (2006) A newly identified leptospiral adhesin mediates attachment to laminin. Infect Immun 74: 6356-6364.
30. Grosskinsky S, Schott M, Brenner C, Cutler SJ, Kraiczy P, et al. (2009) Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity. PLoS One 4: e4858.
31. Hair PS, Ward MD, Semmes OJ, Foster TJ, Cunnion KM, (2008) Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. J Infect Dis 198: 125-133.
32. Lee LY, Hook M, Haviland D, Wetsel RA, Yonter EO, et al. (2004) Inhibition of complement activation by a secreted Staphylococcus aureus protein. J Infect Dis 190: 571-579.
33. Stevenson B, Choy HA, Pinne M, Rotondi ML, Miller MC, et al. (2007) Leptospira interrogans endostatin-like outer membrane proteins bind host fibronectin, laminin and regulators of complement. PLoS One 2: e1188.
34. Beckmann C, Waggoner JD, Harris TO, Tamura GS, Rubens CE, (2002) Identification of novel adhesins from Group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding. Infect Immun 70: 2869-2876.
35. Barbosa AS, Monaris D, Silva LB, Morais ZM, Vasconcellos SA, et al. (2010) Functional characterization of LcpA, a surface-exposed protein of Leptospira spp. that binds the human complement regulator C4BP. Infect Immun 78: 3207-3216.
36. Verma A, Brissette CA, Bowman AA, Shah ST, Zipfel PF, et al. (2010) Leptospiral endostatin-like protein A is a bacterial cell surface receptor for human plasminogen. Infect Immun 78: 2053-2059.
37. Vieira ML, Atzingen MV, Oliveira TR, Oliveira R, Andrade DM, et al. (2010) In vitro identification of novel plasminogen-binding receptors of the pathogen Leptospira interrogans. PLoS One 5: e11259.
38. Vieira ML, de Morais ZM, Vasconcellos SA, Romero EC, Nascimento AL, (2011) In vitro evidence for immune evasion activity by human plasmin associated to pathogenic Leptospira interrogans. Microb Pathog 51: 360-365.
39. Castiblanco-Valencia MM, Fraga TR, da Silva LB, Monaris D, Abreu PAE, et al. (2012) Leptospiral Immunoglobulin-like Proteins Interact With Human Complement Regulators Factor H, FHL-1, FHR-1, and C4BP. J Infect Dis 205: 995-1004.
40. Barbosa AS, Abreu PA, Vasconcellos SA, Morais ZM, Goncales AP, et al. (2009) Immune evasion of Leptospira species by acquisition of human complement regulator C4BP. Infect Immun 77: 1137-1143.
41. Banfi E, Cinco M, Bellini M, Soranzo MR, (1982) The role of antibodies and serum complement in the interaction between macrophages and leptospires. J Gen Microbiol 128: 813-816.
42. Goris MG, Wagenaar JF, Hartskeerl RA, van Gorp EC, Schuller S, et al. (2011) Potent innate immune response to pathogenic Leptospira in human whole blood. PLoS One 6: e18279.
43. Croda J, Ramos JG, Matsunaga J, Queiroz A, Homma A, et al. (2007) Leptospira immunoglobulin-like proteins as a serodiagnostic marker for acute leptospirosis. J Clin Microbiol 45: 1528-1534.
44. Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, et al. (2005) Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol 6: 920-927.
45. Jongerius I, Kohl J, Pandey MK, Ruyken M, van Kessel KP, et al. (2007) Staphylococcal complement evasion by various convertase-blocking molecules. J Exp Med 204: 2461-2471.
46. Hammel M, Sfyroera G, Ricklin D, Magotti P, Lambris JD, et al. (2007) A structural basis for complement inhibition by Staphylococcus aureus. Nat Immunol 8: 430-437.
47. Hammel M, Sfyroera G, Pyrpassopoulos S, Ricklin D, Ramyar KX, et al. (2007) Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus. J Biol Chem 282: 30051-30061.
48. Ricklin D, Tzekou A, Garcia BL, Hammel M, McWhorter WJ, et al. (2009) A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family. J Immunol 183: 2565-2574.
49. Chen H, Ricklin D, Hammel M, Garcia BL, McWhorter WJ, et al. (2010) Allosteric inhibition of complement function by a staphylococcal immune evasion protein. Proc Natl Acad Sci U S A 107: 17621-17626.
50. Jongerius I, Garcia BL, Geisbrecht BV, van Strijp JA, Rooijakkers SH, (2010) Convertase inhibitory properties of staphylococcal extracellular complement-binding protein. J Biol Chem 285: 14973-14979.
51. Alitalo A, Meri T, Ramo L, Jokiranta TS, Heikkila T, et al. (2001) Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. Infect Immun 69: 3685-3691.
52. Hellwage J, Meri T, Heikkila T, Alitalo A, Panelius J, et al. (2001) The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem 276: 8427-8435.
53. Brooks CS, Vuppala SR, Jett AM, Alitalo A, Meri S, et al. (2005) Complement regulator-acquiring surface protein 1 imparts resistance to human serum in Borrelia burgdorferi. J Immunol 175: 3299-3308.
54. Pietikainen J, Meri T, Blom AM, Meri S, (2009) Binding of the complement inhibitor C4b-binding protein to Lyme disease Borreliae. Mol Immunol 47: 1299-1305.
55. Kenedy MR, Vuppala SR, Siegel C, Kraiczy P, Akins DR, (2009) CspA-mediated binding of human factor H inhibits complement deposition and confers serum resistance in Borrelia burgdorferi. Infect Immun 77: 2773-2782.
56. Stevenson B, El-Hage N, Hines MA, Miller JC, Babb K, (2002) Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes. Infect Immun 70: 491-497.
57. Mendes RS, Von Atzingen M, de Morais ZM, Goncales AP, Serrano SM, et al. (2011) The novel leptospiral surface adhesin Lsa20 binds laminin and human plasminogen and is probably expressed during infection. Infect Immun 79: 4657-4667.
58. Papasergi S, Garibaldi M, Tuscano G, Signorino G, Ricci S, et al. (2010) Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells. J Biol Chem 285: 7517-7524.
59. Barthel D, Singh B, Riesbeck K, Zipfel PF, (2012) Haemophilus influenzae uses the surface protein E to acquire human plasminogen and to evade innate immunity. J Immunol 188: 379-385.
60. Hair PS, Echague CG, Sholl AM, Watkins JA, Geoghegan JA, et al. (2010) Clumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phagocytosis. Infect Immun 78: 1717-1727.
61. Meri T, Blom AM, Hartmann A, Lenk D, Meri S, et al. (2004) The hyphal and yeast forms of Candida albicans bind the complement regulator C4b-binding protein. Infect Immun 72: 6633-6641.
62. Kirkitadze MD, Barlow PN, (2001) Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol Rev 180: 146-161.